April 26, 2018
MiMedx Group (MDXG) Q1/18, Q2 and FY18 results and its caveats
April 9, 2018
Regenxbio (RGNX) license with AveXis (AVXS) on Novartis (NVS) acquisition news triggers $180 M pay-day
March 13, 2018
Athersys (ATHX) and HEALIOS K.K. Binding letter of intent to expand MultiStem® Collaboration
March 4, 2018
RegMed Investors’ (RMi) wrapping-up January and February while determining March’s strength …
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors